15:50:43Canada

ProPhase Labs, Inc. (PRPH)

OTC Markets

Key stats Fiscal year 2025

Income statement

Revenue
4,345,000 -35.8%
Net income
-14,743,000
Gross profit
1,384,000
Operating income
-18,047,000
Earnings per share
-1.74
R&D expense
107,000

Growth and profitability

Gross margin
31.85
Operating margin
-415.35
Net margin
-339.31
Return on equity
-420.27
Return on assets
-24.62
Free cash flow margin
-192.04

Balance sheet

Total assets
59,871,000
Total liabilities
56,363,000
Shareholders' equity
3,508,000
Cash and equivalents
90,000
Current ratio
0.06

Cash flow and ratios

Operating cash flow
-8,344,000
Free cash flow
-8,344,000

Shareholder returns

Shares outstanding
15,592,556
Book value per share
0.22
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
New York, NY
Exchange
OTC Markets
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

ProPhase Labs, Inc. trades on OTC Markets under the ticker symbol PRPH. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis